Spectrum Pharmaceuticals Aktie [WKN: 164623 / ISIN: US84763A1088]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Spectrum Pharmaceuticals IncShs

17.03.22		Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update (Businesswire)
11.03.22		Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update (Businesswire)
10.03.22		Spectrum Pharmaceuticals Appoints Juhyun Lim of Hanmi Pharmaceutical to Board of Directors (Businesswire)
07.03.22		Spectrum Pharmaceuticals Presents Positive Data for Poziotinib in First-line NSCLC Patients with HER2 Exon 20 Insertion Mutations (Businesswire)
11.02.22		Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib (Businesswire)
28.01.22		Pre-market Movers: IMPP, PRVB, HOOD, ATIF, WDC… (RTTNews)
27.01.22		Constellation Energy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
20.01.22		Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference (Businesswire)
05.01.22		Spectrum Pharma To Restructure Organization; To Cut Workforce By Approx. 30% (RTTNews)
05.01.22		Spectrum Pharmaceuticals Announces Strategic Restructuring (Businesswire)
04.01.22		Spectrum Pharma Announces Equity Investment By Hanmi Pharma - Quick Facts (RTTNews)
04.01.22		Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical (Businesswire)
06.12.21		Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib (Businesswire)
01.12.21		Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors (Businesswire)
30.11.21		Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit (Businesswire)
28.10.21		ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important November 1 Deadline in Securities Class Action - SPPI (PR Newswire)
06.10.21		ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important November 1 Deadline in Securities Class Action - SPPI (PR Newswire)
20.09.21		Pre-market Movers: VSTM, APRE, SDC, CRVS, HLBZ… (RTTNews)
19.09.21		ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Ac... (PR Newswire)
05.09.21		ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI (PR Newswire)
10.08.21		SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spectrum Pharmaceuticals, Inc. - SPPI (PR Newswire)
06.08.21		(SPPI) Alert: Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Investigation (PR Newswire)
13.05.21		Spectrum Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Update (Businesswire)
06.05.21		Spectrum Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Corporate Update (Businesswire)
10.04.21		Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021 (Businesswire)
05.04.21		Spectrum Pharmaceuticals Presentations at the Upcoming AACR Virtual Meeting 2021 to Include Updated Poziotinib Twice Daily Dosing Data (Businesswire)
30.03.21		Spectrum Pharmaceuticals Reports Fourth Quarter 2020 and Full Year 2020 Financial Results and Pipeline Update (Businesswire)
26.03.21		Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update (Businesswire)
16.03.21		Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection (Businesswire)
11.03.21		FDA Grants Fast Track Designation to Spectrum Pharmaceuticals’ Poziotinib (Businesswire)
02.03.21		Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021 (Businesswire)
26.02.21		Spectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer Conference (Businesswire)
23.02.21		Spectrum Pharmaceuticals Announces Two Presentations at Upcoming ESMO TAT Virtual Congress 2021 (Businesswire)
04.02.21		Spectrum Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2021 Oncology Day (Businesswire)
22.01.21		Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer (Businesswire)
05.01.21		Spectrum Pharmaceuticals to Participate in Three Upcoming Investor Conferences in January (Businesswire)
23.12.20		Pre-market Movers In Healthcare Sector: OCGN, JAGX, ONTX, SRNE, SPPI… (RTTNews)
23.12.20		CYCC Gets $7Mln Strategic Investment, SUPN Abuzz, SNGX Plunges On Oral Mucositis Trial Data (RTTNews)
14.12.20		Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors (Businesswire)
04.12.20		Spectrum Pharmaceuticals Announces Three Poster Presentations at Upcoming San Antonio Breast Cancer Symposium (Businesswire)
09.11.20		Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in November (Businesswire)
04.11.20		Spectrum Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Update (Businesswire)
28.10.20		Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update (Businesswire)
26.10.20		FDA Delays Decision On Spectrum's Neutropenia Drug Due To COVID-19 Related Travel Restrictions (RTTNews)
26.10.20		Spectrum Pharmaceuticals Announces that the FDA is Deferring its Action on the BLA for ROLONTIS® (eflapegrastim) (Businesswire)
26.09.20		Biotech Stocks Facing FDA Decision In October 2020 (RTTNews)
18.09.20		Spectrum Pharmaceuticals Presents Results in HER2 Exon 20 Insertion Mutations from Cohort 2 of the Poziotinib ZENITH20 Clinical Trial (Businesswire)
14.09.20		Spectrum Pharmaceuticals Announces Two Presentations for Poziotinib at ESMO Virtual Congress 2020 (Businesswire)
10.08.20		Spectrum Pharmaceuticals Reports Second Quarter 2020 Financial Results and Corporate Update (Businesswire)
05.08.20		Spectrum Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

voestalpine-Aktie mit Verlusten: Stabile Erdgasversorgung trotz möglicher Unterbrechungen aus Russland

NVIDIA vor Q3-Ergebnissen: Hohe Erwartungen und höhere Kursziele für den KI-Giganten

Solana noch in diesem Jahr bei 300 US-Dollar?

UN-Klimagipfel in Baku: Baerbock warnt vor 'Killerstürmen'

Angespannte Stimmung in Frankfurt: LUS-DAX gibt am Nachmittag nach

BlackRocks Bitcoin-ETF überholt Gold-ETF

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	22.11.2024 17:25
Kaufwert:	EUR
	Hinzufügen Speichern